Mitigating effects of hUCB-MSCs on the hematopoietic syndrome resulting from total body irradiation

Experimental Hematology

Volumn 41, Issue 4, 2013, Pages 346-353.e2

  Shim, Sehwan ^a   Lee, Seung Bum ^b   Lee, Jong Geol ^b   Jang, Won Suk ^b   Lee, Sun Joo ^b   Park, Sunhoo ^b   Lee, Seung Sook ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; KI 67 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE BONE MARROW RADIATION SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; BLOOD EXAMINATION; BONE MARROW; BONE MARROW DISEASE; CELL DENSITY; CELL REGENERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GAMMA RADIATION; HEMATOPOIESIS; HEMATOPOIETIC SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION INJURY; STEM CELL TRANSPLANTATION; TREATMENT DURATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 84876053769     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.01.002     Document Type: Article

References (50)

1. Waselenko J.K., MacVittie T.J., Blakely W.F., et al. Medical management of the acute radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group. Ann Int Med 2004, 140:1037-1051.
2. Zhang Y., Guo C., Zhang H., Dong S. Synergistic protecting effect of cord blood CD34+ cells over-expressing both interleukin-3 and Flt3 ligand on lethally irradiated mice. Int J Hematol 2009, 90:64-73.
3. Mason K.A., Withers H.R., McBride W.H., et al. Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation. Radiat Res 1989, 117:480-488.
4. Xiao M., Whitnall M.H. Pharmacological countermeasures for the acute radiation syndrome. Curr Mol Pharmacol 2009, 2:122-133.
5. Park E., Ahn G.N., Lee N.H., et al. Radioprotective properties of eckol against ionizing radiation in mice. FEBS Lett 2008, 582:925-930.
6. Singh V.K., Grace M.B., Parekh V.I., et al. Effects of genistein administration on cytokine induction in whole-body gamma irradiated mice. Int Immunopharmacol 2009, 9:1401-1410.
7. Wambi C.O., Sanzari J.K., Sayers C.M., et al. Protective effects of dietary antioxidants on proton total-body irradiation-mediated hematopoietic cell and animal survival. Radiat Res 2009, 172:175-186.
8. Weiss J.F., Landauer M.R. History and development of radiation-protective agents. Int J Radiat Biol 2009, 85:539-573.
9. Greenberger J.S., Epperly M. Bone marrow-derived stem cells and radiation response. Semin Radiat Oncol 2009, 19:133-139.
10. Smith T.J., Khatcheressian J., Lyman G.H., et al. 2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 2006, 24:3187-3205.
11. MacVittie T.J., Monroy R.L., Patchen M.L., Souza L.M. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol 1990, 57:723-736.
12. Patchen M.L., MacVittie T.J., Solberg B.D., Souza L.M. Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression. Int J Cell Cloning 1990, 8:107-122.
13. Tanikawa S., Nose M., Aoki Y., et al. Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice. Blood 1990, 76:445-449.
14. Uckun F.M., Souza L., Waddick K.G., et al. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. Blood 1990, 75:638-645.
15. Coleman C.N., Blakely W.F., Fike J.R., et al. Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: Report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat Res 2003, 159:812-834.
16. Herodin F., Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol 2005, 33:1071-1080.
17. Drouet M., Herodin F. Radiation victim management and the haematologist in the future: Time to revisit therapeutic guidelines?. Int J Radiat Biol 2010, 86:636-648.
18. Dainiak N., Waselenko J.K., Armitage J.O., et al. The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program 2003, 473-496.
19. Duarte R.F., Franf D.A. The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): Molecular basis and clinical relevance. Leuk Lymphoma 2002, 43:1179-1187.
20. Liu Q., Jiang B., Jiang L.P., et al. Clinical report of three cases of acute radiation sickness from a (60)Co radiation accident in Henan Province in China. J Radiat Res 2008, 49:63-69.
21. Pape H., Orth K., Heese A., et al. G-CSF during large field radiotherapy reduces bone marrow recovery capacity. Eur J Med Res 2006, 11:322-328.
22. + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 2004, 103:3313-3319.
23. Fouillard L., Chapel A., Bories D., et al. Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia 2007, 21:568-570.
24. Naka K., Muraguchi T., Hoshii T., Hirao A. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal 2008, 10:1883-1894.
25. Geest C.R., Coffer P.J. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol 2009, 86:237-250.
26. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
27. Chaudhary L.R., Spelsberg T.C., Riggs B.L. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: Lack of regulation by 17 beta-estradiol. Endocrinology 1992, 130:2528-2534.
28. Jeong J.A., Hong S.H., Gang E.J., et al. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells 2005, 23:584-593.
29. Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: A new strategy for immunosuppression?. Trends Immunol 2007, 28:219-226.
30. Kim S.M., Oh J.H., Park S.A., et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 2010, 28:2217-2228.
31. Macmillan M.L., Blazar B.R., DeFor T.E., Wagner J.E. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant 2009, 43:447-454.
32. Kim E.S., Ahn S.Y., Im G.H., et al. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res 2012, 72:277-284.
33. Deng X.Y., Zhou R.P., Lu K.W., Jin D.D. Lithium chloride combined with human umbilical cord blood mesenchymal stem cell transplantation for treatment of spinal cord injury in rats [in Chinese]. Nan Fang Yi Ke Da Xue Xue Bao 2010, 30:2436-2439.
34. Lee J.H., Chung W.H., Kang E.H., et al. Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury. J Neurol Sci 2011, 300:86-96.
35. National Research Council. Guide for the care and use of laboratory animals. Available at:. Accessed 1996. http://www.nap.edu/catalog.php%3frecord_id%3d5140.
36. Herodin F., Bourin P., Mayol J.F., Lataillade J.J., Drouet M. Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma irradiation promotes survival. Blood 2003, 101:2609-2616.
37. Johnson L.B., Adawi D., Agren M.S., et al. Combination of pre-operative radiotherapy and surgery suppresses local accumulation of collagen and TGF-beta1 in rats. Journal Surg Res 2006, 133:136-142.
38. Tattini C., Manchio J., Zaporojan V., et al. Role of TGF-beta and FGF in the treatment of radiation-impaired wounds using a novel drug delivery system. Plast Reconstr Surg 2008, 122:1036-1045.
39. Atiba A., Nishimura M., Kakinuma S., et al. Aloe vera oral administration accelerates acute radiation-delayed wound healing by stimulating transforming growth factor-beta and fibroblast growth factor production. Am J Surg 2011, 201:809-818.
40. Hu S., Cucinotta F.A. Characterization of the radiation-damaged precursor cells in bone marrow based on modeling of the peripheral blood granulocytes response. Health Phys 2011, 101:67-78.
41. Knudsen E., Iversen P.O., Boyum A., et al. G-CSF enhances the proliferation and mobilization, but not the maturation rate, of murine myeloid cells. Eur J Haematol 2011, 87:302-311.
42. Theilgaard-Monch K., Jacobsen L.C., Borup R., et al. The transcriptional program of terminal granulocytic differentiation. Blood 2005, 105:1785-1796.
43. Metcalf D. Control of granulocytes and macrophages: Molecular, cellular, and clinical aspects. Science 1991, 254:529-533.
44. Carlsson G., Melin M., Dahl N., et al. Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia. Acta Paediatr 2007, 96:813-819.
45. Horwitz M., Benson K.F., Person R.E., et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999, 23:433-436.
46. Huchet A., Belkacemi Y., Frick J., et al. Plasma Flt-3 ligand concentration correlated with radiation-induced bone marrow damage during local fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:508-515.
47. Bertho J.M., Demarquay C., Frick J., et al. Level of Flt3-ligand in plasma: A possible new bio-indicator for radiation-induced aplasia. Int J Radiat Biol 2001, 77:703-712.
48. Prat M., Demarquay C., Frick J., Thierry D., Gorin N.C., Bertho J.M. Radiation-induced increase in plasma Flt3 ligand concentration in mice: Evidence for the implication of several cell types. Radiat Res 2005, 163:408-417.
49. Wodnar-Filipowicz A., Lyman S.D., Gratwohl A., et al. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 1996, 88:4493-4499.
50. Kajioka E.H., Andres M.L., Mao X.W., et al. Hematological and TGF-beta variations after whole-body proton irradiation. In Vivo 2000, 14:703-708.